Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neuroendocrine Tumors 2 D018358 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 138661-02-6
ChEMBL CHEMBL2108757
FDA SRS G083B71P98
PubChem 72128